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he cells responsible for production of the male sex
hormone testosterone, the Leydig cells of the testis,
are post-mitotic cells with neuroendocrine charac-
teristics. Their origin during ontogeny and regeneration
processes is still a matter of debate. Here, we show that
cells of testicular blood vessels, namely vascular smooth
muscle cells and pericytes, are the progenitors of Leydig
cells. Resembling stem cells of the nervous system, the
Leydig cell progenitors are characterized by the expression
of nestin. Using an in vivo model to induce and monitor
T
 
the synchronized generation of a completely new Leydig
cell population in adult rats, we demonstrate speciﬁc pro-
liferation of vascular progenitors and their subsequent
transdifferentiation into steroidogenic Leydig cells which,
in addition, rapidly acquire neuronal and glial properties.
These ﬁndings, shown to be representative also for on-
togenetic Leydig cell formation and for the human tes-
tis, provide further evidence that cellular components of
blood vessels can act as progenitor cells for organogenesis
and repair.
 
Introduction
 
The temporally regulated emergence during ontogeny of the
testosterone-producing Leydig cells is essential for the proper
development of male individuals. This includes the presence/
activity of distinct phenotypes arising prenatally (“fetal” Ley-
dig cells) or during puberty (“adult” Leydig cells), respectively
(for reviews see Ge et al., 1996; Habert et al., 2001; Mendis-
Handagama and Ariyaratne, 2001). Despite considerable efforts,
the origin of the Leydig cells is still a matter of debate (Benton
et al., 1995; Ariyaratne et al., 2000; Habert et al., 2001; Brennan
and Capel, 2004). Based on the realization of neural character-
istics of Leydig cells (Schulze et al., 1987; Davidoff et al.,
1993, 1999, 2002), we asked whether cells distinguished by the
expression of the intermediate filament protein nestin, which
have been established to act as stem/progenitor cells in the
nervous system (Lendahl et al., 1990; Rietze et al., 2001;
Sahlgren et al., 2001), could be involved also in the genera-
tion of Leydig cells. To address this issue, we made use of an
experimental model where a single injection of the cytotoxic
compound ethane dimethane sulphonate (EDS) into adult rats
initially eliminates the existing Leydig cell population, which
is followed by a synchronized and complete Leydig cell regen-
eration (Teerds, 1996). By this approach, we identified vascular
smooth muscle cells (VSMCs) and pericytes (PCs) as the pro-
genitors of all Leydig cell phenotypes, indicating that vascular
cell types, acting like adult stem cells, play a critical role in
organ formation.
 
Results
 
The time period of Leydig cell 
disappearance is characterized by 
elevated nestin expression
 
To prove and document reliably the known fate of Leydig cells
in the rat testis after a single i.p. EDS injection, we monitored
the expression of a Leydig cell marker protein, cytochrome
P450 side chain cleavage enzyme (CytP450), representing the
rate-limiting enzyme of steroidogenesis. CytP450-immunore-
active cells completely disappeared 3 d after EDS treatment
and began to reappear 
 
 
 
14 d after EDS treatment, detectable
primarily as cell clusters located in the vicinity of intertubular
vessels (Fig. 1 a) and in form of single, peritubularly distrib-
uted spindle-shaped cells (Fig. 1 b). At this time, the total
amount of Leydig cells is still very low (Fig. 1 c), and the
expression of CytP450 is not yet detectable by immunoblotting
(see Fig. 2 a).
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At d 21 after EDS, the number of CytP450-immunoreac-
tive Leydig cells has increased vigorously, and its overwhelm-
ing majority is now peritubularly localized. (Fig. 1 d). By d 30
after EDS administration, the number of peritubular Leydig
cells has decreased, and the cells are now accumulated prefer-
entially within the intertubular connective tissue (Fig. 1 e), re-
sembling the localization of Leydig cells in normal adult testes.
To investigate whether nestin is expressed in testis, we
initially performed immunoblot analyses. These studies were
capable of demonstrating low levels of nestin, detectable as
a protein of 
 
 
 
440 kD (Kachinsky et al., 1995), in normal
(untreated) 3-mo-old animals. However, the expression in
testis of nestin was rapidly and massively enhanced after
EDS treatment (Fig. 2 a), and the most significant eleva-
tion was observed precisely until the onset of massive Ley-
dig cell regeneration (see the analogous immunoblot for
CytP450). Thus, Leydig cell disappearance clearly coincides
with elevation, and Leydig cell reappearance with diminution
of nestin expression.
 
VSMCs and PCs are the sites of nestin 
expression and show pronounced cell 
division activity
 
Immunohistochemical analyses showed that nestin is localized
to the testicular microvasculature. There is clear evidence that
VSMCs are the sites of nestin immunoreactivity, whereas en-
dothelial cells are nestin negative (Fig. 2, b and c). Note in ad-
dition (see Fig. 2 c) the occurrence in some larger blood vessels
of either nestin
 
 
 
 (arrowhead) or nestin
 
 
 
 (arrow) VSMCs. Se-
lected sections displaying the transition from precapillaries to
capillaries demonstrate that PCs, in addition to VSMCs, are the
sites of nestin expression (Fig. 2 d). Such sections served also
to demonstrate coexpression of nestin (Fig. 2 d) and smooth
muscle 
 
 
 
-actin (SMA; Fig. 2 e) in these cells. In addition, 2 d
after EDS administration, only these vascular wall cell types
(Fig. 2 f) display nuclear labeling by BrdU (to examine divid-
ing cells, the animals had been injected with BrdU 2 h before
decapitation and organ dissection), indicating their prolifera-
tive activity. The principal distribution pattern of nestin immu-
noreactivity in testis at d 2 after EDS, localized to the intertu-
bular and peritubular microvasculature (Fig. 2 g), and the
pronounced mitotic activity at that time of VSMCs and PCs at
a peritubular position (Fig. 2 h) are illustrated. We note that the
contractile peritubular myoid cells neither express nestin nor
show mitotic activity. Comprehensive immunohistochemical
analyses proved that the increase in nestin expression during
the first week after EDS injection (as assessed by immunoblot-
ting) is based on an increase in the number of nestin-immu-
noreactive VSMCs and PCs.
 
Nestin-expressing VSMCs and PCs 
protrude from vessel walls and are 
transformed into Leydig cells
 
14 d after EDS, nestin-positive cells begin to protrude from
the vessel walls (Fig. 3, a–c) and to accumulate in their vicin-
ity in form of clusters (Fig. 3 d), strikingly similar to the
(CytP450 immunoreactive) Leydig cell clusters observed at
that time (Fig. 1 a). Conditions where these cell clusters are
still in contact with the blood vessel walls they derive from
are detectable (Fig. 3 c). As revealed by double staining, the
clusters consist of cells expressing either both nestin and
CytP450, or only CytP450 (Fig. 3, e and f), indicating a pro-
cess in which nestin-immunoreactive cells, during and/or after
their displacement from vessel walls, first acquire steroi-
dogenic properties (expression of CytP450) and then loose
nestin, finally resulting in typical Leydig cells. This conver-
sion into Leydig cells is accompanied also by a loss of SMA
immunoreactivity (not depicted), providing further evidence
for a transdifferentiation phenomenon. Approximately 1 wk
later, when newly formed Leydig cells are abundant and local-
ized primarily around the tubular compartments, nestin ex-
pression is generally reduced but still clearly detectable at
larger blood vessels (Fig. 3 g). Newly formed Leydig cells
that still display nestin immunoreactivity are only rarely to be
found at d 20 (Fig. 3 h) and are nearly undetectable at d 21
(Fig. 3 i), indicating a faster transformation process at that
time. In contrast to the situation early after EDS treatment, the
rapid and abundant transformation is not accompanied by a
pronounced cell division activity. Note that the number of
BrdU-labeled nuclei of stem cell–like progenitors is several
fold higher at d 2 (Fig. 3 j) than at d 21 after EDS (Fig. 3 k).
Thus, proliferation of the Leydig cell progenitors predomi-
nates during the first week after EDS, whereas their transfor-
mation begins at d 14 and accelerates 1 wk later.
Figure 1. Reappearance of Leydig cells after EDS treatment. Leydig
(CytP450-immunoreactive) cells are first detectable near blood vessels
(arrows) in the form of clusters (a) or as single spindle-shaped cells (b) in
testes 14 d after EDS. The cluster (white arrow) and spindle-shaped cell
(black arrow) magnified in a and b, respectively, are indicated in c. The
accumulation of Leydig cells at d 21 (d) and d 30 (e) after EDS, distributed
around (d) and between (e) seminiferous tubules, is shown. 
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Leydig cell progenitors and Leydig cells 
are characterized by the distinct 
expression of neuronal/glial markers
 
Next, we examined intermediate filament proteins that are ex-
pressed subsequent to nestin in cells of the nervous system dur-
ing their differentiation into the neuronal/glial lineage (Dahl-
strand et al., 1995; Doetsch, 2003). These studies revealed a
conspicuous regulation of neurofilament-H (NF-H). Its expres-
sion in testis increases (first detectable at d 7) later than that of
nestin (d 1, see Fig. 2 a) and is sustained at high levels for a rel-
atively short time (around d 14) after EDS exposure (Fig. 4 a).
Thus, transiently elevated expression of NF-H, localized to the
vascular Leydig cell progenitors (Fig. 4 b), coincides with their
transition from proliferative to transformation activity.
In contrast to NF-H, which is detectable only at low lev-
els also in Leydig cells (Davidoff et al., 1999), the glial fibril-
lary acidic protein (GFAP) was found to be predominantly ex-
pressed in these cells. Consistently, GFAP levels are scarcely
detectable by immunoblotting during the period of Leydig cell
depletion (Fig. 4 a). The Leydig cell–specific expression of
GFAP was confirmed by immunohistochemical analyses, dem-
onstrating localization to Leydig cells (Fig. 4 c). Further stud-
ies revealed that newly generated Leydig cells, independent on
their intertubular (Fig. 4, d, e, and h; 14 d after EDS) or peritu-
bular (Fig. 4, f and g; 21 d after EDS) site of generation, rapidly
become immunoreactive for diverse neuronal markers such as
growth-associated protein 43 (Fig. 4 d), tyrosine kinase A (Fig.
4, e and f), glial cell line–derived neurotrophic factor (Fig. 4 g),
neural cell adhesion molecule (Fig. 4 h), neuron-specific
enolase, microtubule-associated protein-2, synaptophysin, and
NeuroD (not depicted), as well as for GFAP (Fig. 4 c), 2
 
 
 
,3
 
 
 
-
cyclic nucleotide 3
 
 
 
-phosphodiesterase, and A2B5-antigen (not
depicted), known to be expressed by astrocytes, oligodendro-
cytes, and glial progenitor cells, respectively (Davidoff et al.,
Figure 2. EDS exposure induces testicular nestin expres-
sion, localized to VSMCs and PCs. (a) Immunoblots dem-
onstrate increased nestin expression during the period of
Leydig cell (see levels of CytP450) depletion. (b–d) Immu-
nohistochemical analyses show that nestin is localized to
vascular smooth muscle cells (VSMC) and pericytes (PC)
(d), but not to endothelial cells (EC; see b and c, with
longitudinal orientation) of testicular blood vessels. (e)
VSMCs and PCs are stained for smooth muscle  -actin
(SMA). (f–h) At d 2 after EDS, VSMCs and PCs proliferate
as indicated by nuclear incorporation of BrdU (f and h).
The testicular distribution of nestin immunoreactivity at
that time, localized to large intertubular as well as to
peritubular (arrows) vessels, is shown in g. Higher magnifi-
cation of an area corresponding to the box marked in g
demonstrates proliferating (BrdU labeled) cells of the peri-
tubular microvasculature (h, arrows). Note that some
spermatogonia (arrowheads) are also detectable. The
lumen of a blood vessel filled with erythrocytes is marked
by an asterisk. T, seminiferous tubules. 
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2002). Thus, after transformation from vascular progenitors,
the Leydig cells are distinguished by the expression of several
neuronal/glial markers, indicative of a remarkable pluripotent
neural phenotype.
Next, we examined the proteoglycan NG2, known to be
expressed in neuronal and glial cell progenitors of the central
and peripheral nervous system (Schneider et al., 2001; Chek-
enya et al., 2002; Belachew et al., 2003) and previously sug-
gested as a marker for PCs (Ozerdem et al., 2001). Like nestin
(see Fig. 2 and Fig. 3), NG2 immunoreactivity was found both
in VSMCs and PCs (Fig. 4, i–k), as well as in newly generated
Leydig cells (Fig. 4 k), further indicating a relationship between
these cell types. Finally, the selective identification of PDGF re-
ceptor-
 
 
 
 (PDGFR-
 
 
 
; Fig. 4, l and m), known to be involved in
development of VSMCs and PCs (Lindahl et al., 1997; Lindahl
and Betsholtz, 1998; Hellström et al., 2001; Hoch and Soriano,
2003; Lindblom et al., 2003), and myelin/oligodendrocyte-spe-
cific protein (not depicted) immunoreactivity in both newly
generated (at d 14 after EDS) Leydig cells and their vascular
progenitors, strongly supported their lineage relationship.
 
Leydig cell generation during postnatal 
development shows similarities to the 
Leydig cell repopulation process after 
EDS treatment
 
Next, we investigated whether the regeneration of Leydig cells
after EDS treatment has similarities to the formation of a mature
Leydig cell population in rats during normal postnatal develop-
ment. Immunoblot analyses of Cyt P450scc revealed a biphasic
expression pattern (Fig. 5 a): protein levels most significantly
increase during puberty (d 24 and 27) to attain maximum (i.e.,
adult) values, but there is also an elevated expression at the ear-
liest (postnatal day 5) stage examined. This developmental pat-
tern is consistent with a gradual decrease in the number of fetal-
type Leydig cells during initial postnatal development followed
by the appearance and plentiful accumulation of adult-type Ley-
dig cells (Ge et al., 1996). Comparative analyses of nestin and
NF-H revealed striking similarities to the Leydig cell repopula-
tion process after EDS treatment. Nestin expression is initially
high and declines in time with the abundant emergence of
(adult) Leydig cells, whereas the postnatal expression of NF-H
Figure 3. Nestin-expressing cells protrude
from blood vessel walls and transform into
Leydig cells. 14 d after EDS, nestin-immunore-
active cells begin to protrude (arrows) from in-
tertubular vessel walls (a and b) and begin to
form cell clusters in their direct vicinity (c and d).
The orientation of such a vessel between
newly formed cell clusters (d, indicated by an
arrow) and sites where transdifferentiating
progenitor cells are still in contact with the ves-
sel they derive from (c, red arrows) are
shown. These clusters consist of cells that either
coexpress nestin (brown) and CytP450 (blue),
or express Cyt P450 only (e and f). 1 wk later,
nestin
  cells are visible at a peritubular position
(g and h), and newly formed Leydig cells are
only occasionally (h, day 20) or not at all (i,
day 21) nestin positive. At this time (k, day
21), the number of proliferating (BrdU labeled)
vascular wall cells (arrows) is much lower than
at d 2 after EDS (j). T, seminiferous tubules. 
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commences later (between d 5 and 10) and peaks (around d 15)
before the switch from nestin to CytP450 expression (Fig. 5 a).
At the cellular level, VSMCs and PCs as well as fetal-
type Leydig cells are the major sites of nestin expression
during early (d 5) postnatal development (Fig. 5 b), and the for-
mation of Leydig cell clusters at blood vessels is detectable
similar to the situation 14 d after EDS treatment (Fig. 5 b).
During puberty (postnatal day 27; Fig. 5 c), nestin-positive
vascular cells are visible in close proximity to seminiferous
tubules and large intertubular vessels. Nestin
 
 
 
 VSMCs are trace-
able also in testes of adult rats (Fig. 5 d). Their distinct local-
ization to blood vessels within Leydig cell groups is indicative
of a continuous generation of new Leydig cells by transforma-
tion from nestin
 
 
 
 progenitors in the mature testis.
 
Analyses of nestin-GFP transgenic mice 
and human testes
 
As in rats, a similar pattern of nestin-immunoreactive cells was
found in testes of adult mice (unpublished data). To verify the
sites of nestin expression by a different approach, we made use of
nestin-GFP transgenic mice. These studies, performed with ani-
mals expressing GFP under the control of the central nervous sys-
tem (CNS)–specific nestin second intronic enhancer (Lothian and
Lendahl, 1997; Mignone et al., 2004), confirmed the expression of
nestin in Leydig cells and their vascular progenitors (Fig. 5, e–g).
Finally, comparative analyses revealed that this is also
valid for the human testis (Fig. 5 h). Remarkably, numerous
(still nestin-immunoreactive) newly formed Leydig cells are
detectable within areas of Leydig cell hyperplasia in testes of
elderly men (Fig. 5 i). Thus, transformation of stem cell–like
progenitors into Leydig cells can explain (hitherto incompre-
hensible) increases in the number of Leydig cells (Clegg et al.,
1997) despite their lack of mitotic activity (Teerds et al., 1989;
Benton et al., 1995).
 
Discussion
 
Identification of vascular Leydig cell 
progenitors
 
This paper identifies VSMCs and PCs as the progenitors of
Leydig cells (summarized in Fig. 6). We show that the Leydig
cell progenitor cells are characterized by (1) the expression of
nestin, a marker protein for stem cells of the nervous system
(Lendahl et al., 1990; Rietze et al., 2001; Sahlgren et al., 2001);
(2) a transient up-regulation in these cells of NF-H, known to
be expressed in the nervous system during the differentiation of
stem cells into the neuronal lineage (Dahlstrand et al., 1995);
and (3) that the newly formed Leydig cells rapidly become im-
munoreactive for diverse neuronal and glial markers. Thus,
three independent lines of evidence point to a similarity be-
Figure 4. Neural characteristics of Leydig cells and their
vascular progenitors. (a) Immunoblots show transiently
elevated levels of NF-H and a reduced expression of
GFAP in testis during the period of Leydig cell depletion
after EDS treatment. VSMCs, but not endothelial cells
(EC, marked by an arrow), are the sites of NF-H expres-
sion (b). In contrast, newly formed Leydig cells are immu-
noreactive for GFAP (c), GAP43 (d), TrkA (e and f),
GDNF (g), and N-CAM (h). Both VSMCs (i, arrow) and
PCs (j and k, arrowheads), as well as newly formed Leydig
cells (k, LC), are characterized by the expression of
NG2, and Leydig cells (LC) together with their vascular
progenitors (VSMC, arrow; PCs, arrowheads) are sites of
PDGFR-  expression (l and m). T, seminiferous tubules. 
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tween the vascular Leydig cell progenitors and stem cells/pro-
genitors of the nervous system, consistent with and supporting
findings (for review see Carmeliet, 2003) that neural and vas-
cular systems use common genetic pathways. In this context,
the recent identification of a factor (Arx), implicated in both
brain development and Leydig cell differentiation (Kitamura et
al., 2002), has to be noted.
The in vivo model used in this study was crucial for the
identification of the Leydig cell progenitors. We revealed that
after EDS treatment, Leydig cell regeneration is preceded by a
specifically induced proliferation of nestin-expressing VSMCs
and PCs, and we were capable of demonstrating the dynamic
process of their conversion into steroidogenic Leydig cells.
These findings were substantiated by immunoblot analyses that
clearly demonstrated, both in the EDS model and during post-
natal development, the functional interrelation between the
quantity of progenitor cells (indicated by nestin levels) and the
quantity of Leydig cells (indicated by CytP450 levels). It will
be of interest to identify the signaling pathways implicated in
the activation of progenitor proliferation as well as in trigger-
ing the transdifferentiation processes in (pre)pubertal and adult
animals. Data obtained by analyzing fetal Leydig cell develop-
ment refer to PDGFs, acting via PDGFRs 
 
 
 
/
 
 
 
 (Gnessi et al.,
2000; Basciani et al., 2002; Brennan et al., 2003; Hoch and So-
riano, 2003) and Desert hedgehog (Clark et al., 2000; Yao et
al., 2002) as possible candidate molecules. In addition, factors
such as bone morphogenetic proteins, known to regulate cell
fate choice and differentiation of CNS stem cells (Rajan et al.,
2003), have to be considered.
 
Nestin expression in testis
 
Although a functional role for nestin is still poorly understood,
its specific expression in activated/dynamic cells (e.g., cells
that proliferate, migrate, or rapidly change their phenotype) is
well established (Sahlgren et al., 2001). Originally identified as
a marker for neural progenitor cells during early stages of CNS
development (Lendahl et al., 1990), it was meanwhile demon-
strated that nestin is also expressed in a variety of tissues out-
side the CNS (Vaittinen et al., 2001; Zulewski et al., 2001; Li
et al., 2003) and in the adult organism during regeneration of
injured tissue (Frisén et al., 1995; Okano, 2002). Our present
findings demonstrate elevated nestin expression in testis both
during development as well as during regeneration after exper-
imentally induced Leydig cell elimination in adult animals.
Figure 5. Nestin expression in testis during rat ontoge-
netic development, in nestin-GFP transgenic mice, and
adult humans. (a) Immunoblots show the regulation in rat
testis of CytP450, nestin, and NF-H during postnatal devel-
opment. (b–d) The distribution of nestin-immunoreactive
structures in rat testis at postnatal days 5 (b), 27 (c) and 90
(d) is shown. (e–g) GFP expression in testes of transgenic
mice expressing GFP under the control of the nestin
second-intron enhancer (green fluorescence) is detectable
in Leydig cells and their vascular progenitors based on
morphology (arrows point to PCs). In g, nuclei are addi-
tionally marked by DAPI (blue). (h and i) Immunohis-
tochemical staining for nestin on adult human testis sections
from individuals without (h) or with (i) Leydig cell hyperpla-
sia. Tubular compartments (T), Leydig cells (LC), and nestin-
positive vessels (arrows) are indicated. In i, stars mark the
lumen of a small vessel. 
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Consistent with observations in other tissues (Lendahl et al.,
1990; Sejersen and Lendahl, 1993), nestin was found to be
down-regulated and replaced by other intermediate filament
proteins upon terminal differentiation. Nestin expression was
clearly localized to PCs/VSMCs and newly generated Leydig
cells in rat, mouse, and human testes. This characteristic pat-
tern was additionally verified by the analysis of nestin-GFP
transgenic animals. It has to be noted that the nestin-GFP mice
used in our study direct transgene expression to cell types of
neural origin (Mignone et al., 2004), and that GFP was found to
be expressed selectively in the adult brain in areas related to
continuous neurogenesis (Mignone et al., 2004). Thus, the
identification in these animals of GFP in testicular vascular
wall (PCs, VSMCs) cells and Leydig cells essentially supports
similarity to properties of neural stem/progenitor cells. It is of
interest that the mean number of nestin-expressing Leydig cells
in mouse (detectable both in the GFP model and by immuno-
histochemistry in wild-type mice; unpublished data) as well as
in human testes is significantly higher than in rat testes, sug-
gesting species-specific differences in the velocity of nestin
down-regulation after terminal differentiation.
 
Lineage relationship between PCs, 
VSMCs, and Leydig cells
 
The present paper reveals a close relationship between PCs
and VSMCs of the testis microvasculature. Both cell types ex-
press SMA and nestin and proliferate in response to EDS
treatment. The identification of NG2 and PDGFR-
 
 
 
 immu-
noreactivity in both cell types corroborates their relationship,
and in addition demonstrates properties similar to those of
neural progenitors of the CNS (Belachew et al., 2003). These
findings are consistent with several previous reports, indicat-
ing functional (Allt and Lawrenson, 2001; Hoofnagle et al.,
2004; Hu et al., 2004) or lineage (Alliot et al., 1999; Korn et
al., 2002) relationship between PCs and VSMCs. Evidence
for their transdifferentiation into Leydig cells is based on
clear coincidence of marker expression, i.e., transient coex-
pression of nestin with CytP450 in newly generated Leydig
cells. Moreover, the observed connection of newly formed
Leydig cell clusters with the blood vessel walls further dem-
onstrates their origin, and previously detected basement mem-
brane fragments at the cell surface of certain Leydig cells
(Kuopio and Pelliniemi, 1989; Haider et al., 1995) probably
represent remnants of the basal lamina known to surround
PCs (Sims, 1991; Nehls and Drenckhahn, 1993). Consistently,
immunoreactivity for NG2 and for PDGFR-
 
 
 
, recently estab-
lished as reliable markers for activated PCs (Ozerdem and
Stallcup, 2003) as well as for myelin/oligodendrocyte-specific
protein, was identified in both newly generated Leydig cells
and their vascular progenitors. Finally, lineage relationship
was significantly supported by analyses of nestin-GFP trans-
genic mice, showing specific (and selective) expression of the
transgene in Leydig cells and their progenitors.
The potential involvement of circulating cells in the pro-
cess of Leydig cell (re)generation requires attention. However,
several lines of evidence argue against such a possibility. The
observed immediate induction of proliferation/nestin expres-
sion in PCs and VSMCs during the EDS-elicited Leydig cell
destruction strongly refers to resident cells, rapidly responding
to newly generated and/or disappearing (testosterone) signaling
molecules. Furthermore, immunohistochemical analyses, per-
formed with antibodies against the mesodermal/hematopoietic
stem cell marker CD34, did not reveal any marker expression in
PCs or SMVCs of the testis microvasculature, whereas staining
was detectable in endothelial and intertubular connective tissue
cells (unpublished data). These findings, indicating an involve-
ment of resident rather than circulating cells, are consistent
with cellular activities responsible for increased nestin expres-
sion after injury in other tissues (Frisén et al., 1995; Amoh et
al., 2004). Remarkably, a recent investigation, identifying so-
called side population (SP) cells in testis (Kubota et al., 2003),
Figure 6. Schematic representation of transdifferentiation of vascular
progenitors into Leydig cells. (a) Nestin-expressing (black) vascular smooth
muscle cells (VSMC) and pericytes (PC) of testicular blood vessels, but not
endothelial cells (EC) or peritubular myoid cells (MC), vigorously proliferate
(indicated by red-labeled nuclei) during the first week after EDS-induced
Leydig cell depletion. (b) Around d 14 after EDS, nestin-expressing
VSMCs and PCs, now marked also by a transient expression of NF-H
(green contour line), begin to protrude from intertubular vessels and begin
to form cell clusters. By transdifferentiation, the cells first acquire ste-
roidogenic properties (yellow, black dotted) and finally loose nestin, result-
ing in typical (yellow) Leydig cells (LC). (c and d) Time scale of Leydig cell
(re)generation after EDS treatment (c) and during ontogenetic develop-
ment (d). (c) Leydig cell depletion, marked by the absence of CytP450
(yellow), rapidly induces nestin expression (black) and proliferation activity
(red). The conversion of proliferative into transformation activity (yellow,
black dotted) is preceded by a transient expression of NF-H (green). (d) A
similar correlation between CytP450, nestin, and NF-H expression is de-
tectable during postnatal testis development. 
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showed that testis SP cells do not derive from or contain circu-
lating blood cells, but represent resident cells in this tissue.
Considering that many of the properties of Leydig cells
and their progenitors are compatible with a neural crest origin
(Davidoff et al., 1993, 1999, 2002; Lobo et al., 2004), we started
to address this issue experimentally. However, investigations of
mice with targeted mutations (see Materials and methods) in
genes of the neural crest–specific neuregulin receptors, ErbB2
and ErbB3 (Britsch et al., 1998), did not yet reveal clear-cut re-
sults. In this context, it might be of general interest that we rec-
ognized during these studies endogenous 
 
 
 
-galactosidase ex-
pression in different testicular cell types (unpublished data),
which precludes a reliable characterization of testes of transgenic
animals expressing 
 
 
 
-galactosidase fusion proteins.
 
Leydig cell heterogeneity
 
Furthermore, our observations regarding the different Leydig
cell phenotypes are worth mentioning. We noted that the hy-
pertrophied cells arising first in the form of clusters during the
Leydig cell repopulation process resemble typical fetal-type
cells, whereas the second-arising spindle-shaped cells are sim-
ilar to the so-called intermediate-type cells that are generated
as early stages of adult Leydig cells. Although all phenotypes
derive from (the same) nestin-positive vascular progenitor
cells, the fetal-type cells strictly emerge at intertubular and the
intermediate-/adult-type cells at peritubular sites. This strongly
suggests local environmental effects (Kerr et al., 1987; Teerds,
1996; Gnessi et al., 2000), which are assumed to be responsi-
ble also for the observed differences in the extent of Leydig
cell regeneration between tubules with either high or low re-
covery of spermatogenesis.
In conclusion, the conversion of VSMCs into neuroendo-
crine Leydig cells represents a novel example of transdifferen-
tiation (Echeverri and Tanaka, 2002; Tosh and Slack, 2002) in
vivo and demonstrates that blood vessels not only provide in-
ductive signals (Lammert et al., 2001) but also cellular compo-
nents (progenitor cells) other than the mesoangioblasts, a
recently characterized class of vessel-associated stem cells
(Sampaolesi et al., 2003), for tissue generation and repair. In
the testis, the vascular progenitors identified probably contrib-
ute to regulation of Leydig cell number during aging and under
conditions of Leydig cell hyperplasia/tumorigenesis.
 
Materials and methods
 
Materials and tissues
 
EDS was synthesized in our laboratory from ethylene glycol and methane sul-
fonylchloride as described by Jackson and Jackson (1984); BrdU and di-
methylsulfoxide were purchased from Sigma-Aldrich. Testes and other or-
gans from male Wistar rats of different ontogenetic stages (Charles River
Laboratories) were dissected immediately after decapitation of the animals.
Human testes, obtained from patients undergoing orchiectomy as the primary
treatment of prostatic carcinoma, were chilled and cut 1–2 h after surgery.
 
EDS treatment and proliferation assays
 
Adult (3-mo-old, 340–380 g) male Wistar rats were housed three per
cage under standard laboratory conditions. To induce Leydig cell deple-
tion, animals received single i.p. injections (75 mg EDS/kg body weight,
dissolved in 25% dimethylsulfoxide). The rats were killed 1–48 d after
EDS injection. For assessment of mitotic cells, EDS-treated animals re-
ceived i.p. injections of BrdU (150 mg/kg body weight, dissolved in 0.09 M
NaOH) 2 h before killing. Tissues were dissected immediately after de-
capitation of the animals and were either frozen in liquid nitrogen or fixed
in Bouin’s fluid. The rats were used according to government principles
regarding the care and use of animals with permission (G8151/591-
00.33) of the local regulatory authority.
 
Mouse strains
 
The generation of nestin-GFP transgenic mice, expressing GFP under the
control of the nestin gene promoter and a transcriptional enhancer that re-
sides in the second intron of the gene, has been described previously
(Mignone et al., 2004). To address certain questions regarding a poten-
tial neural crest origin of Leydig cells, we used mice with targeted muta-
tions in genes of tyrosine kinase receptors of the ErbB family (Britsch et al.,
1998). The mutants examined either express ErbB2/
 
 
 
-galactosidase fu-
sion proteins or represent ErbB3 knockouts.
 
Immunohistochemical and fluorescence analyses
 
Immunohistochemistry, based on peroxidase activity, and specificity con-
trols on paraffin sections were performed essentially as described previ-
ously (Davidoff et al., 1993, 1999, 2002) using commercially available
primary antibodies: anti-CytP450 (working dilution 1:300), anti–rat (MAB
353, 1:500), anti–human (AB 5922, 1:300) nestin, rabbit anti-NG2 (NG2
chondroitin sulfate proteoglycan; 1:300), and anti-MOSP (mouse anti-myelin/
oligodendrocyte-specific protein 1:2,000) from CHEMICON International;
anti-NF-H (1:200), anti-GFAP (1:1,000), anti-SMA (1:400), anti-GAP43
(1:1,000), anti-GDNF (2 
 
 
 
g/ml), and anti-N-CAM (1:200) from Sigma-
Aldrich; anti-TrkA (1:100) as well as anti-PDGFR-
 
 
 
 (P-20; 1:50) from Santa
Cruz Biotechnology, Inc.; rat anti–mouse CD34 (1:100) from BD Bio-
sciences; and mouse anti–human CD34 (1:100) from DakoCytomation.
In case of double staining, the second antigen was detected by al-
kaline phosphatase activity. We used substrate staining (rather than immu-
nofluorescence) deliberately in these experiments to clearly identify and
examine transdifferentiating cells in their normal tissue context (i.e., to-
gether with all neighboring cells). For visualization of BrdU, sections were
pretreated with 1 M HCl in PBS/0.3% Triton X-100 for 30 min at 37
 
 
 
C fol-
lowed by 30 min with PBS/2% normal rabbit serum before incubation
with anti-BrdU (clone BMC 9318, diluted 1:20 in PBS containing BSA and
sodium azide; Roche) for 18–24 h at 4
 
 
 
C.
For detection of GFP fluorescence, adult nestin-GFP transgenic male
mice were transcardially perfused with 4% PFA in PBS. After additional im-
mersion fixation for 4 h at RT and impregnation with 30% sucrose-PB, the
testes were frozen in liquid nitrogen, and cryostat sections (8, 10, and 20
 
 
 
m) were mounted onto histological slides. After drying for 30 min at RT,
the sections were coverslipped with DakoCytomation fluorescent mounting
medium. Cell nuclei of certain sections were additionally stained with DAPI.
 
Immunoblot analyses
 
Soluble and particulate fractions of tissue homogenates, prepared as de-
scribed previously (Middendorff et al., 2002), were size fractionated by
SDS-PAGE under reducing conditions in 6% (for detection of nestin and
NF-H) or 9% (CytP450, GFAP) acrylamide gels and transferred to nitrocel-
lulose membranes. In the immunoblots shown, equal amounts (80 
 
 
 
g pro-
tein) of either soluble (nestin, NF-H) or particulate (CytP450, GFAP) frac-
tions were applied, and rat brain proteins were coanalyzed to serve as
positive controls in case of the neural antigens examined. The membranes
were probed with antibodies against nestin (MAB 353, diluted 1:1,000;
CHEMICON International), CytP450 (AB 1244, 1:1,000; CHEMICON
International), NF-H (1:750; Biotrend), or GFAP (1:450; Sigma-Aldrich).
After incubations with peroxidase-linked anti–mouse (1:2,000; Pierce
Chemical Co., Perbio Science) or anti–rabbit (1:2,000; Sigma-Aldrich)
secondary antibodies, signals were detected using ECL (Amersham Bio-
sciences) on x-ray films.
 
Photographic documentation
 
Photographic documentation was made using an Axioskop microscope
(Carl Zeiss MicroImaging, Inc.) equipped with the analogous 36 
 
 
 
 24-mm
microscopic camera (MC-100; Carl Zeiss MicroImaging, Inc.) and a 9 
 
 
 
12-cm Polaroid camera. The photographic negatives (black and white) and
slides (colored) were subsequently scanned and additionally processed us-
ing Adobe Photoshop 7.0 and Adobe Illustrator 10 (Adobe Systems, Inc.).
GFP fluorescence was viewed using a fluorescence microscope (Ax-
ioskop-2; Carl Zeiss MicroImaging, Inc.) equipped with appropriate filter
combinations. Images were taken with a digital camera (AxioCam HRc;
Carl Zeiss MicroImaging, Inc.) and stored at a size of 1300 
 
 
 
 1030 pix-
els. Images were assembled with Adobe Photoshop and Adobe Illustrator
programs (see above). 
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